Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by rome1on May 26, 2010 4:34pm
638 Views
Post# 17133762

RE: This is not TA

RE: This is not TA
I honestly can't believe they extended the warrants to June 30th with the hope that Tuesday's news release was all they had. Obviously better news was expected but that alone did not guarantee the purchase of the 50 cent warrants.

I know they had another ace up their sleeve to build off of those results....which would guarantee the the exercising of those warrants about to expire in a month.

There has been talk for a very long time of U.S. military involvement in the TBI trial.....which we have not heard a peep about in months. Was that their ace so to speak? I am sure they had something else....and hope like many, it has not evaporated in the last couple days.

Time will tell.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse